This reduction may be explained by the intensification of hepatitis B surveillance measures for blood transfusions and the introduction of hepatitis B vaccination in the Expanded Program of Immunisation in CAR in 2008. The gene discussed is PPIB; the disease is hepatitis A virus infection.